Assessment of Efficacy and Safety of Mangifera indica Extract (Stadice®) for Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Study

被引:1
|
作者
Jeyakodi, Shankaranarayanan [1 ]
Krishnakumar, Arunkanth [1 ]
Dalal, Meena [2 ]
Shetty, B. Sohandas [2 ]
机构
[1] Zeus Hygia Lifesciences Pvt Ltd, Res & Dev, Hyderabad, Pakistan
[2] TrialGuna Pvt Ltd, Clin Res, Bengaluru, India
关键词
learning and memory; cognitive health; alertness; focus; esports; mangifera indica; mangiferin; stadice (R); DEFICITS;
D O I
10.7759/cureus.65751
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Stadice (R) (R) is a proprietary herbal ingredient preparation standardized to mangiferin, developed to support cognitive wellness in healthy adults. Mangifera indica extract and its active constituent, mangiferin were known for its positive cognitive health benefits at experimental levels. This was an attempt to evaluate the clinical efficacy and safety of Stadice (R) (R) on healthy subjects. Materials and methods A randomized, double-blind, placebo-controlled clinical study was designed to study the efficacy and safety of Stadice (R). (R) . Sixty healthy subjects who were regularly playing virtual/mobile/computer/laptop games online or offline were asked to consume a capsule containing 300 mg of Stadice (R) (R) or placebo per day for seven days. Cognitive ability tests, that were part of the NIMHANS Neuropsychological Battery and Auditory verbal learning tests were used to assess the cognitive health effects. Psychological stress response, anxiety, mood, subjective working memory, and cortisol levels were also assessed. All assessments were carried out at the baseline and at the end of the study. Results Stadice (R) (R) was found to significantly improve mental speed, attention, working memory, response inhibition, and verbal learning and memory as evidenced by the results of the multiple cognitive ability tests. Additionally, Stadice (R) (R) showed beneficial responses in managing psychological stress in terms of handling nervousness, irritability, or mood swings. No safety concerns were found in the laboratory safety test parameters as they were within the normal physiological range and no adverse events were reported in this study. Conclusion The proprietaryMangifera Mangifera indica extract (Stadice (R)) (R) ) holds promise for enhancing cognitive abilities in healthy adults, particularly those engaged in esports. Improvements in learning, memory, mental speed, attention, response inhibition, and working memory among participants supplemented with Stadice (R) (R) were observed with a good safety profile. Further exploration is warranted to ascertain its broader applicability as well as to elucidate the possible mechanisms.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
    McIntyre, Roger S.
    Lophaven, Soren
    Olsen, Christina K.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 (10) : 1557 - 1567
  • [2] Acute effects of mango leaf extract on cognitive function in healthy adults: a randomised, double-blind, placebo-controlled crossover study
    Dodd, Fiona L.
    Kennedy, David O.
    Johnson, Jodee
    Haworth, Emily
    Greener, Jessica P.
    Jackson, Philippa A.
    FRONTIERS IN NUTRITION, 2024, 11
  • [3] A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder
    Mahableshwarkar, Atul R.
    Zajecka, John
    Jacobson, William
    Chen, Yinzhong
    Keefe, Richard S. E.
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (08) : 2025 - 2037
  • [4] Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial
    Mahdavinasab, Seyedeh-Mahsa
    Saghazadeh, Amene
    Motamed-Gorji, Nogol
    Vaseghi, Salar
    Mohammadi, Mohammad-Reza
    Alichani, Rosa
    Akhondzadeh, Shahin
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2019, 28 (12) : 1619 - 1628
  • [5] Efficacy of Donepezil in Improving Cognitive Impairment Induced by Electroconvulsive Therapy in Patients with Mood Disorders: A Randomized, Double-blind, Placebo-Controlled Trial
    Zarean, Elham
    Sedehi, Morteza
    Heshmati, Yalda
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2021, 15 (03)
  • [6] A randomized, double-blind, placebo-controlled, phase IIa, clinical study on investigating the efficacy and safety of SPH3127 tablet in patients with essential hypertension
    Wang, Fang
    Liu, Ling
    Ruan, Hongyun
    Chen, Xiaoping
    Zhang, Yue
    Yu, Zaixin
    Li, Yuhui
    Guan, Yang
    Wang, Jiguang
    Huang, Kai
    Yu, Shunjiang
    Cao, Yuanyuan
    Ding, Cungang
    Chang, Lin
    Huang, Yaohua
    Chen, Xiangjuan
    Lv, Qiang
    Ma, Changsheng
    HYPERTENSION RESEARCH, 2024, 47 (07) : 1925 - 1933
  • [7] Efficacy and safety of Hominis placenta pharmacopuncture on mild cognitive impairment Randomized, double blind, placebo-controlled, multi-center trial
    Kim, Yunna
    Lee, Jae Hyok
    Jung, In Chul
    Eom, Yoon Ji
    Cho, Seung-Hun
    MEDICINE, 2020, 99 (46) : E22956
  • [8] Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study
    Rai, Hari Prakash
    Mishra, Deo Nidhi
    JOURNAL OF PSYCHOPHARMACOLOGY, 2025, 39 (04) : 350 - 363
  • [9] Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia
    Keefe, Richard S. E.
    Meltzer, Herbert A.
    Dgetluck, Nancy
    Gawryl, Maria
    Koenig, Gerhard
    Moebius, Hans J.
    Lombardo, Ilise
    Hilt, Dana C.
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 (13) : 3053 - 3060
  • [10] Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
    Brown, David
    Nakagome, Kazuyuki
    Cordes, Joachim
    Brenner, Ronald
    Gruender, Gerhard
    Keefe, Richard S. E.
    Riesenberg, Robert
    Walling, David P.
    Daniels, Kristen
    Wang, Lara
    McGinniss, Jennifer
    Sand, Michael
    SCHIZOPHRENIA BULLETIN, 2019, 45 (02) : 350 - 359